Therapeutic Potential of Selected Flavonoids as Natural Antidiabetic Agents
Nutrients · 2026
DOI: 10.3390/nu18182944 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2026. Verfasst von Klaudia Stocerz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, Medical University of Silesia in Katowice, 15 Poniatowskiego Str., 40-055 Katowice, Poland. Hauptthemen laut MEDLINE: Flavonoids, Hypoglycemic Agents, Diabetes Mellitus, Type 2. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia.
Abstract (Originalsprache)
Type 2 diabetes mellitus (T2DM) remains a major clinical challenge, with postprandial hyperglycemia (PPG) playing a key role in the development of vascular complications. Current pharmacotherapies often do not sufficiently control PPG, highlighting the need for complementary strategies. One effective approach is the inhibition of carbohydrate digesting enzymes, α-amylase and α-glucosidase, which delays glucose absorption and reduces PPG excursions. Flavonoids, a diverse class of plant-derived polyphenols, exhibit multiple biological activities relevant to T2DM, including enzyme inhibition, antioxidant, and anti-inflammatory effects. This review summarizes the mechanisms by which flavonoids modulate glucose metabolism, with particular emphasis on their interactions with α-amylase and α-glucosidase. Structure–activity relationships are discussed, focusing on the influence of hydroxylation patterns, conjugation, and molecular planarity on inhibitory potency and selectivity. Selected flavonoids—chrysin, apigenin, luteolin, and quercetin—are comparatively analyzed in terms of enzyme inhibition profiles, binding mechanisms, and selectivity. Evidence from in vitro studies, enzyme kinetics, and molecular docking highlights their differential activity, particularly the preferential inhibition of α-glucosidase over α-amylase, which may reduce gastrointestinal side effects. Overall, flavonoids represent promising modulators of PPG. However, their clinical relevance is limited by bioavailability and variability of experimental data, warranting further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Doctoral School, Medical University of Silesia in Katowice, 15 Poniatowskiego Str., 40-055 Katowice, Poland.
- Department of Community Pharmacy, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 8b Jednosci Str., 41-200 Sosnowiec, Poland.
- Department of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 4 Jagiellonska Str., 41-200 Sosnowiec, Poland.
ORCID-Profile: Klaudia Stocerz, Arkadiusz Sokal, Patryk Mruczek, Monika Kadela-Tomanek, Paweł Ramos
Förderung
- Medical University of Silesia
Zitieren
APA
Stocerz, K., Sokal, A., Mruczek, P., Kadela-Tomanek, M., & Ramos, P. (2026). Therapeutic Potential of Selected Flavonoids as Natural Antidiabetic Agents. Nutrients. https://doi.org/10.3390/nu18182944
Vancouver
Stocerz K, Sokal A, Mruczek P, Kadela-Tomanek M, Ramos P. Therapeutic Potential of Selected Flavonoids as Natural Antidiabetic Agents. Nutrients. 2026. doi:10.3390/nu18182944
BibTeX
@article{Stocerz2026,
author = {Stocerz, Klaudia and Sokal, Arkadiusz and Mruczek, Patryk and Kadela-Tomanek, Monika and Ramos, Paweł},
title = {Therapeutic Potential of Selected Flavonoids as Natural Antidiabetic Agents},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18182944}
}
EUVIMED